C196H177F4N47O12 — CID 160565940
N-(4-cyanophenyl)-5-[5-[(4-hydroxypiperidin-1-yl)methyl]-3-pyridinyl]-1H-indazole-3-carboxamide;N-(4-cyanophenyl)-5-[5-(morpholin-4-ylmethyl)-3-pyridinyl]-1H-indazole-3-carboxamide;N-(4-cyanophenyl)-5-(5-phenoxy-3-pyridinyl)-1H-indazole-3-carboxamide;5-[5-[(4,4-difluoropiperidin-1-yl)methyl]-3-pyridinyl]-N-(6-methyl-3-pyridinyl)-1H-indazole-3-carboxamide;5-[5-[(3,3-difluoropyrrolidin-1-yl)methyl]-3-pyridinyl]-N-(6-methyl-3-pyridinyl)-1H-indazole-3-carboxamide;N-(6-methyl-3-pyridinyl)-5-(5-morpholin-4-yl-3-pyridinyl)-1H-indazole-3-carboxamide;N-(6-methyl-3-pyridinyl)-5-(5-piperidin-1-yl-3-pyridinyl)-1H-indazole-3-carboxamide;N-(6-methyl-3-pyridinyl)-5-(5-pyrrolidin-1-yl-3-pyridinyl)-1H-indazole-3-carboxamide (PubChem CID 160565940) has the molecular formula C196H177F4N47O12 and a molecular weight of 3458.88 g/mol. Its IUPAC name is N-(4-cyanophenyl)-5-[5-[(4-hydroxypiperidin-1-yl)methyl]-3-pyridinyl]-1H-indazole-3-carboxamide;N-(4-cyanophenyl)-5-[5-(morpholin-4-ylmethyl)-3-pyridinyl]-1H-indazole-3-carboxamide;N-(4-cyanophenyl)-5-(5-phenoxy-3-pyridinyl)-1H-indazole-3-carboxamide;5-[5-[(4,4-difluoropiperidin-1-yl)methyl]-3-pyridinyl]-N-(6-methyl-3-pyridinyl)-1H-indazole-3-carboxamide;5-[5-[(3,3-difluoropyrrolidin-1-yl)methyl]-3-pyridinyl]-N-(6-methyl-3-pyridinyl)-1H-indazole-3-carboxamide;N-(6-methyl-3-pyridinyl)-5-(5-morpholin-4-yl-3-pyridinyl)-1H-indazole-3-carboxamide;N-(6-methyl-3-pyridinyl)-5-(5-piperidin-1-yl-3-pyridinyl)-1H-indazole-3-carboxamide;N-(6-methyl-3-pyridinyl)-5-(5-pyrrolidin-1-yl-3-pyridinyl)-1H-indazole-3-carboxamide.
| Compound Name | N-(4-cyanophenyl)-5-[5-[(4-hydroxypiperidin-1-yl)methyl]-3-pyridinyl]-1H-indazole-3-carboxamide;N-(4-cyanophenyl)-5-[5-(morpholin-4-ylmethyl)-3-pyridinyl]-1H-indazole-3-carboxamide;N-(4-cyanophenyl)-5-(5-phenoxy-3-pyridinyl)-1H-indazole-3-carboxamide;5-[5-[(4,4-difluoropiperidin-1-yl)methyl]-3-pyridinyl]-N-(6-methyl-3-pyridinyl)-1H-indazole-3-carboxamide;5-[5-[(3,3-difluoropyrrolidin-1-yl)methyl]-3-pyridinyl]-N-(6-methyl-3-pyridinyl)-1H-indazole-3-carboxamide;N-(6-methyl-3-pyridinyl)-5-(5-morpholin-4-yl-3-pyridinyl)-1H-indazole-3-carboxamide;N-(6-methyl-3-pyridinyl)-5-(5-piperidin-1-yl-3-pyridinyl)-1H-indazole-3-carboxamide;N-(6-methyl-3-pyridinyl)-5-(5-pyrrolidin-1-yl-3-pyridinyl)-1H-indazole-3-carboxamide |
|---|---|
| PubChem CID | 160565940 |
| Molecular Formula | C196H177F4N47O12 |
| Molecular Weight | 3458.88 g/mol |
| Exact Mass | 3456.46 |
| IUPAC Name | N-(4-cyanophenyl)-5-[5-[(4-hydroxypiperidin-1-yl)methyl]-3-pyridinyl]-1H-indazole-3-carboxamide;N-(4-cyanophenyl)-5-[5-(morpholin-4-ylmethyl)-3-pyridinyl]-1H-indazole-3-carboxamide;N-(4-cyanophenyl)-5-(5-phenoxy-3-pyridinyl)-1H-indazole-3-carboxamide;5-[5-[(4,4-difluoropiperidin-1-yl)methyl]-3-pyridinyl]-N-(6-methyl-3-pyridinyl)-1H-indazole-3-carboxamide;5-[5-[(3,3-difluoropyrrolidin-1-yl)methyl]-3-pyridinyl]-N-(6-methyl-3-pyridinyl)-1H-indazole-3-carboxamide;N-(6-methyl-3-pyridinyl)-5-(5-morpholin-4-yl-3-pyridinyl)-1H-indazole-3-carboxamide;N-(6-methyl-3-pyridinyl)-5-(5-piperidin-1-yl-3-pyridinyl)-1H-indazole-3-carboxamide;N-(6-methyl-3-pyridinyl)-5-(5-pyrrolidin-1-yl-3-pyridinyl)-1H-indazole-3-carboxamide |
| SMILES | Cc1ccc(NC(=O)c2n[nH]c3ccc(-c4cncc(CN5CCC(F)(F)C5)c4)cc23)cn1.Cc1ccc(NC(=O)c2n[nH]c3ccc(-c4cncc(CN5CCC(F)(F)CC5)c4)cc23)cn1.Cc1ccc(NC(=O)c2n[nH]c3ccc(-c4cncc(N5CCCC5)c4)cc23)cn1.Cc1ccc(NC(=O)c2n[nH]c3ccc(-c4cncc(N5CCCCC5)c4)cc23)cn1.Cc1ccc(NC(=O)c2n[nH]c3ccc(-c4cncc(N5CCOCC5)c4)cc23)cn1.N#Cc1ccc(NC(=O)c2n[nH]c3ccc(-c4cncc(CN5CCC(O)CC5)c4)cc23)cc1.N#Cc1ccc(NC(=O)c2n[nH]c3ccc(-c4cncc(CN5CCOCC5)c4)cc23)cc1.N#Cc1ccc(NC(=O)c2n[nH]c3ccc(-c4cncc(Oc5ccccc5)c4)cc23)cc1 |
| InChI | InChI=1S/C26H24N6O2.C26H17N5O2.C25H24F2N6O.C25H22N6O2.C24H22F2N6O.C24H24N6O.C23H22N6O2.C23H22N6O/c27-13-17-1-4-21(5-2-17)29-26(34)25-23-12-19(3-6-24(23)30-31-25)20-11-18(14-28-15-20)16-32-9-7-22(33)8-10-32;27-14-17-6-9-20(10-7-17)29-26(32)25-23-13-18(8-11-24(23)30-31-25)19-12-22(16-28-15-19)33-21-4-2-1-3-5-21;1-16-2-4-20(14-29-16)30-24(34)23-21-11-18(3-5-22(21)31-32-23)19-10-17(12-28-13-19)15-33-8-6-25(26,27)7-9-33;26-13-17-1-4-21(5-2-17)28-25(32)24-22-12-19(3-6-23(22)29-30-24)20-11-18(14-27-15-20)16-31-7-9-33-10-8-31;1-15-2-4-19(12-28-15)29-23(33)22-20-9-17(3-5-21(20)30-31-22)18-8-16(10-27-11-18)13-32-7-6-24(25,26)14-32;1-16-5-7-19(14-26-16)27-24(31)23-21-12-17(6-8-22(21)28-29-23)18-11-20(15-25-13-18)30-9-3-2-4-10-30;1-15-2-4-18(13-25-15)26-23(30)22-20-11-16(3-5-21(20)27-28-22)17-10-19(14-24-12-17)29-6-8-31-9-7-29;1-15-4-6-18(13-25-15)26-23(30)22-20-11-16(5-7-21(20)27-28-22)17-10-19(14-24-12-17)29-8-2-3-9-29/h1-6,11-12,14-15,22,33H,7-10,16H2,(H,29,34)(H,30,31);1-13,15-16H,(H,29,32)(H,30,31);2-5,10-14H,6-9,15H2,1H3,(H,30,34)(H,31,32);1-6,11-12,14-15H,7-10,16H2,(H,28,32)(H,29,30);2-5,8-12H,6-7,13-14H2,1H3,(H,29,33)(H,30,31);5-8,11-15H,2-4,9-10H2,1H3,(H,27,31)(H,28,29);2-5,10-14H,6-9H2,1H3,(H,26,30)(H,27,28);4-7,10-14H,2-3,8-9H2,1H3,(H,26,30)(H,27,28) |
| InChIKey | QZXOOTYNBOIAFD-UHFFFAOYSA-N |
| XLogP | 34.23 |
| TPSA | 771.78 Ų |
| H-Bond Donors | 17 |
| H-Bond Acceptors | 43 |
| Rotatable Bonds | 37 |
| Heavy Atoms | 259 |
| Complexity | — |
4 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 3458.88 |
| LogP ≤ 5 | 34.23 |
| H-Bond Donors ≤ 5 | 17 |
| H-Bond Acceptors ≤ 10 | 43 |